Drug intelligence / Profile preview

Chlorhexidine and Chitosan Combination

Development stage
Unknown
Modality
Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration
Topical
01

Overview

The combination of chlorhexidine and chitosan represents a synergistic formulation that has shown enhanced efficacy in dental applications, particularly for plaque control and reducing gingival inflammation. ## Efficacy and Mechanism Chlorhexidine is a well-established antiseptic agent with broad antimicrobial properties, while chitosan is a natural biopolymer derived from chitin with bioadhesive properties. When combined, these agents demonstrate a synergistic effect that appears superior to either component used alone[1][2]. Studies have shown that the chlorhexidine-chitosan combination provides: - Significantly greater reduction in plaque indices compared to either agent used individually[1] - Enhanced antibacterial activity against oral bacteria, including streptococci[2] - Superior antiplaque effects through the combination of chitosan's bioadhesive properties with chlorhexidine's antimicrobial activity[2][3] ## Clinical Applications The primary applications for this combination include: - Dental plaque control - Reduction of gingival inflammation - Potential use in mouthwashes and oral care products - Wound healing applications ## Safety Profile Chitosan is generally considered safe when used for up to 3 months, though it may cause minor side effects like stomach upset, constipation, or gas when taken orally[4]. Chlorhexidine is widely used as an antiseptic and disinfectant for wounds and oral care. ## Formulations The combination has been studied in various formulations: - Mouthwash solutions (typically containing 0.2% chlorhexidine with 0.5-2% chitosan)[1] - Gel-based coatings[5] - Wound dressings[6] This combination represents an innovative approach to improving antiplaque strategies by leveraging the complementary properties of both compounds.

02

Targets

PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on Chlorhexidine and Chitosan Combination.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chlorhexidine and Chitosan Combination.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call